A 60-year-old with symptomatic PAD undergoes femoropopliteal stenting. Which antithrombotic regimen is guideline-supported post-revascularization to r...

Question

A 60-year-old with symptomatic PAD undergoes femoropopliteal stenting. Which antithrombotic regimen is guideline-supported post-revascularization to reduce limb and CV events (no high bleeding risk)?

Accepted Answer

Low-dose rivaroxaban 2.5 mg BID plus aspirin long-term

Answer

Aspirin alone indefinitely

Answer

Clopidogrel alone indefinitely

Answer

Dual antiplatelet therapy for 12 months only

Answer

Warfarin with INR 2.5-3.5

us-abim MCQ (SBA): PAD Post-Revascularization

A 60-year-old with symptomatic PAD undergoes femoropopliteal stenting. Which antithrombotic regimen is guideline-supported post-revascularization to reduce limb and CV events (no high bleeding risk)?